tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

ALLR Stock Latest News

Allarity Therapeutics Nears Regulatory Approval with Stenoparib Trial Success
Company AnnouncementsAllarity Therapeutics Nears Regulatory Approval with Stenoparib Trial Success
3d ago
8K
ALLR
Allarity announces two patients exceeding one year treatment with stenoparib
PremiumThe Fly
Allarity announces two patients exceeding one year treatment with stenoparib
4d ago
ALLR
Allarity Therapeutics Revamps Finance Strategy and Leadership
PremiumCompany Announcements
Allarity Therapeutics Revamps Finance Strategy and Leadership
7d ago
8K
ALLR
Allarity appoints Alex Epshinsky as CFO
PremiumThe Fly
Allarity appoints Alex Epshinsky as CFO
7d ago
ALLR
ATXI
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PremiumPress Releases
Allarity Therapeutics Announces New CFO and Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
7d ago
ALLR
Allarity takes step toward regaining Nasdaq compliance
PremiumThe FlyAllarity takes step toward regaining Nasdaq compliance
9d ago
ALLR
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)
Premium
Press Releases
Allarity Therapeutics Takes Decisive Step Toward Regaining Nasdaq Compliance with Nasdaq Listing Rule 5550(a)(2)
9d ago
ALLR
Allarity Therapeutics Inc trading halted, news pending
Premium
The Fly
Allarity Therapeutics Inc trading halted, news pending
9d ago
ALLR
Allarity Therapeutics Stockholders Approve Key Corporate Changes
PremiumCompany Announcements
Allarity Therapeutics Stockholders Approve Key Corporate Changes
11d ago
8K
ALLR
Allarity files to sell 18.53M shares of common stock for holders
PremiumThe Fly
Allarity files to sell 18.53M shares of common stock for holders
20d ago
ALLR
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
PremiumPress Releases
Allarity Therapeutics Announces Postponement of Annual Stockholders Meeting
2M ago
ALLR
Allarity announces postponement of Annual Stockholders Meeting
PremiumThe Fly
Allarity announces postponement of Annual Stockholders Meeting
2M ago
ALLR
Allarity urges shareholders to vote for reverse stock split, decrease in shares
PremiumThe FlyAllarity urges shareholders to vote for reverse stock split, decrease in shares
2M ago
ALLR
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares
Premium
Press Releases
Allarity Encourages Shareholders to Vote FOR the Reverse Stock Split and Decrease in Authorized Shares
2M ago
ALLR
Allarity Therapeutics Shares 2024 Milestones and Vision
Premium
Company Announcements
Allarity Therapeutics Shares 2024 Milestones and Vision
2M ago
8K
ALLR
Allarity provides 2024 corporate update
PremiumThe Fly
Allarity provides 2024 corporate update
2M ago
ALLR
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
PremiumPress Releases
Allarity Therapeutics Outlines Company’s 2024 Progress and Objectives
2M ago
ALLR
Allarity Therapeutics Secures Critical Nasdaq Hearing Opportunity
PremiumCompany Announcements
Allarity Therapeutics Secures Critical Nasdaq Hearing Opportunity
3M ago
8K
ALLR
Allarity granted hearing before Nasdaq to present plan of regaining compliance
PremiumThe Fly
Allarity granted hearing before Nasdaq to present plan of regaining compliance
3M ago
ALLR
Allarity Therapeutics Reports Promising Ovarian Cancer Trial Progress
PremiumCompany AnnouncementsAllarity Therapeutics Reports Promising Ovarian Cancer Trial Progress
3M ago
8K
ALLR
Allarity: Stenoparib continues to show clinical benefit in ovarian cancer
Premium
The Fly
Allarity: Stenoparib continues to show clinical benefit in ovarian cancer
3M ago
ALLR
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
Premium
Press Releases
Allarity Therapeutics’ Dual PARP/Tankyrase Inhibitor, Stenoparib, Continues to Show Extended Clinical Benefit in Advanced Ovarian Cancer
3M ago
ALLR

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >